EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.
A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can minimize flare risk and support the successful discontinuation of GCs in ...
In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).
Chip Chick on MSN5mon
A New Study Has Identified A Root Cause Of Lupus And A Way To Potentially Reverse The Chronic Autoimmune Disease, Which Affects Over 1.5 Million People In The U.S.If the effects of the methods are durable, perhaps they can be applied to all cases of lupus. The new study points to the ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.
Hosted on MSN4mon
New drug to combat debilitating immune system disorder lupusPatients living with a debilitating immune system disorder that can lead to skin rashes, joint pain and even death are set to receive ground-breaking new treatment. The condition, lupus ...
Systemic lupus erythematosus is associated with substantial ... more targeted therapeutic interventions and the development of new biological drugs. [2] In this paper, we review the findings ...
More than 100 autoantibodies have been identified in lupus, opening up promising new R&D pathways to potentially deliver precision therapeutics. 11 Biogen is working to deliver the industry’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback